iHeart Japan Corporation
PrivateLast Round
Series D
Sep 1, 2025
Total Funding Raised
$29.73M
Company Overview
iHeart Japan Corporation is a biotechnology company that develops allogeneic regenerative medical products derived from iPS cells for the treatment of heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iHeart Japan Corporation Comparables
Compare iHeart Japan Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cuorips Inc. | 87% | |
| Heartseed | 85% | |
| Avery Therapeutics, Inc. | 77% |
iHeart Japan Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2025 | ||||
| Series C | Jul 6, 2021 | ||||
| Series A | Nov 30, 2017 | ||||
| Series B | May 16, 2016 |
iHeart Japan Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SMBC Nikko Securities | Series D |
| UTEC (The University of Tokyo Edge Capital Partners) | Series D |
| Joyo Capital Partners | Series D |
| Resona Capital | Series C |
| Mitsui Sumitomo Insurance | Series D |
| 株式会社ヘルスケア・イノベーション | Series D |
| Miraidoa | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
$6M round led by MS&AD Ventures and Mitsui Sumitomo Insurance
- Jul 6, 2021
$7.2M round from Miraidoa and NCB Venture Capital.
iHeart Japan Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iHeart Japan Corporation's valuation, stock price, and market status.
Is iHeart Japan Corporation a public or private company?
iHeart Japan Corporation is a private company.
What is the current stock price of iHeart Japan Corporation?
iHeart Japan Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is iHeart Japan Corporation worth (valuation)?
Valuation information for iHeart Japan Corporation is not publicly available.
Can I buy iHeart Japan Corporation stock?
iHeart Japan Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iHeart Japan Corporation's last funding round?
iHeart Japan Corporation's most recent funding round was Series D on September 1, 2025.
Who are the main investors in iHeart Japan Corporation?
Key investors in iHeart Japan Corporation include Mitsui Sumitomo Insurance, MS&AD Ventures.
Will iHeart Japan Corporation IPO soon?
No public IPO plans have been announced for iHeart Japan Corporation.
How can I track iHeart Japan Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iHeart Japan Corporation's secondary market activity and sign up for updates.